Chemical Compound

Doxorubicin Hydrochloride

CAS Registry Number 25316-40-9

Back to search Request a Quote

Primary Record

Doxorubicin Hydrochloride

In stock: 1,566 g
Purity: 99.8 %
CAS: 25316-40-9

Compound Identifiers & Properties

CAS: 25316-40-9
PubChem CID: 443939
SMILES: C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl
Canonical SMILES: COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl

Names & Synonyms

Doxorubicin Hydrochloride
Adriamycin
Doxorubicin HCl
25316-40-9
Adriblastina
Adriacin
Rubex
Doxil
Adriblastin
Adriamycin PFS
Adriamycin RDF
Caelyx
Adriablastina cs
Adrosal
Duxocin
Lipodox
doxorubicin.HCl
adriamycine
drochloride
Farmiblastina
Adrimedac
Doxorubin
Resmycin
Doxolem
Ellence
Lipo-Dox
ADM hydrochloride
Adriblastina RD
Doxourbicin HCl
ADRIAMYCIN HYDROCHLORIDE
Urokit Doxo cell
Urokit Doxo-cell
icin Hydrochloride
Adriamycin (TN)
DOXO cell
DOXO-cell
Doxorubicin citrate
Hydroxydaunorubicin hydrochloride
Adriacin (TN)
Prestwick_188
Doxorubicin (Adriamycin) HCl
ADRIAMYCIN, HYDROCHLORIDE
Doxil (TN)
Rubex (TN)
Doxorubicin (hydrochloride)
Doxorubicini hydrochloridum
RefChem:5781
hydroxydaunomycin hydrochloride
MFCD00077757
AC1L9FFU
Adriblastina hydrochloride
Doxorubicin citric acid salt
Doxorubicine hydrochloride
82F2G7BL4E
ADRIAMYCIN [IARC]
DOXIL (LIPOSOMAL)
Doxorubicin hydrochloride?
UNII-82F2G7BL4E
2-Amino-3-chloropyrazine
Hydrochloride, Doxorubicin
CCRIS 740
DTXSID3030636
D0F4KU
Chloridrato de Doxorrubicina
MLS001401460
SCHEMBL3242
Doxorubicin hydrochloride RS
DSSTox_CID_10636
DSSTox_RID_80678
Doxorubicin hydrochloride [JAN]
DSSTox_GSID_45111
Doxorubicin hydrochloride CRS
DTXCID1010636
C27H30ClNO11
MLS000028393
MLS000049969
MLS000049970
MLS000049971
MLS000070047
MLS000392861
MLS000392871
MLS000392881
MLS000392891
MLS000392901
MLS000759533
MLS001055359
C27H29NO11.ClH
CAS-NOCAS_45111
KW-125
Liposomal doxorubicin hydrochloride
MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL359744
orb1310036
SCHEMBL29349501
SCHEMBL29567127
CHEBI:31522
EINECS 246-818-3
AOB5216
Doxorubicin hydrochloride [USP:JAN]
Doxorubicin hydrochloride solution
BCPP000429
GLXC-06425
HMS1569G18
HMS6018M19
KUC110341C
MSK001346A
NSC 123127
doxorubicin hydrochloride, Liposomal
DRG-0047
EX-A1337
FI 6804
14-Hydroxydaunorubicin Hydrochloride
Adriamycin hydrochloride-DNA complex
C27-H29-N-O11.Cl-H
Tox21_110050
Tox21_112061
Tox21_202483
Adriamycin (Doxorubicin Hydrochloride
BBF-03859
CD0186
CID443939
Doxorubicin hydrochloride (liposomal)
DOXORUBICIN HYDROCHLORIDE LIPOSOME
EBC-11150
FI 106
FI-106
HB4183
HY-15142R
NSC123127
s1208
CPD000058570
DOXORUBICIN HYDROCHLORIDE 25MG
SMR000058570
AKOS007930231
AKOS015920241
Doxorubicin hydrochloride (JP18/USP)
Tox21_110050_1
ACN-036671
ACN-036867
AD15377
BCP9000237
CCG-100975
CS-1239
Doxorubicin (hydrochloride) (Standard)
DOXORUBICIN HYDROCHLORIDE 100MG
F.I 106
NC00225
NSC-123127
RL02839
2-Chloro-4-fluorobenzenesulphonylchloride
3-Hydroxyacetyldaunorubicin Hydrochloride
Daunorubicin EP Impurity D hydrochloride
DOXORUBICIN HYDROCHLORIDE [MART.]
DOXORUBICIN HYDROCHLORIDE [VANDF]
NCGC00014486-01
NCGC00024415-33
NCGC00024415-36
NCGC00163543-01
NCGC00260032-01
NCGC00263918-03
AD184265
AS-31687
BD164391
BR-72874
DOXORUBICIN HYDROCHLORIDE [USP-RS]
DOXORUBICIN HYDROCHLORIDE [WHO-DD]
DOXORUBICIN HYDROCHLORIDE [WHO-IP]
HY-15142
SAM001246768
SY059508
KSC-230-184-1
AB0069925
CAS-25316-40-9
Doxorubicin hydrochloride =95% (by HPLC)
DOXORUBICIN HYDROCHLORIDE [EMA EPAR]
ST2419270
A1832
Doxorubicin hydrochloride - Bio-X trade mark
Doxorubicin liposomal complex of the hydrochloride
FT-0625594
FT-0777536
NS00093622
A10041
D01275
DOXORUBICIN HYDROCHLORIDE [EP MONOGRAPH]
DOXORUBICIN HYDROCHLORIDE [ORANGE BOOK]
EN300-123444
W-5070
33804-EP2275420A1
33804-EP2295055A2
33804-EP2295416A2
33804-EP2298748A2
33804-EP2298764A1
33804-EP2298765A1
33804-EP2305642A2
33804-EP2308833A2
33804-EP2311453A1
DOXORUBICIN HYDROCHLORIDE [USP MONOGRAPH]
139293-EP2270008A1
139293-EP2292617A1
316D409
A817779
DOXORUBICIN HYDROCHLORIDE LIPOSOME [VANDF]
DOXORUBICINI HYDROCHLORIDUM [WHO-IP LATIN]
F021790
SR-01000003049
(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
Doxorubicin hydrochloride, 10 mg/ml aqueous solution
Doxorubicin hydrochloride, 98.0-102.0% (HPLC)
IMX-110 COMPONENT DOXORUBICIN HYDROCHLORIDE
LIPOSOMAL DOXORUBICIN HYDROCHLORIDE [WHO-DD]
SR-01000003049-5
Q27032359
SR-01000003049-10
23214-92-8
Z1557399790
Doxorubicin hydrochloride, 98%, an antibiotic agent - 1G 1g
DOXORUBICIN LIPOSOMAL COMPLEX OF THE HYDROCHLORIDE [MI]
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
(8S,10S)-10-{[(2R,4S,5S,6S)-4-AMINO-5-HYDROXY-6-METHYLOXAN-2-YL]OXY}-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-5,7,8,9,10,12-HEXAHYDROTETRACENE-5,12-DIONE HYDROCHLORIDE
(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-
Doxorubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Doxorubicin hydrochloride, suitable for fluorescence, 98.0-102.0% (HPLC)
Doxorubicin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Doxorubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard
(1S,3S)-3,5,12-Trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside--hydrogen chloride (1/1)
(2S,4S)-4-(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-2,5,12-trihydroxy-2-hydroxyacetyl-7-methoxy-1,2,3,4-tetrahydrotetracene-6,11-dione monohydrochloride
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
(8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracen
(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hy
(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride
(8S,10S)-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
(8S,10S)-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-GLYCOLOYL-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-5,12-NAPHTHACENEDIONE HYDROCHLORIDE
(8S,10S)-10-[[(2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
10-[(3-Amino-2,3,6-trideoxy-?-L-lyxohexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-5,12-naphthacenedione hydrochloride
5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYLACETYL)-1-METHOXY-, HYDROCHLORIDE (8S-CIS)-
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride, (8S-cis)-
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride (8S-cis)-
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
5,12-NAPHTHACENEDIONE, 10-[(3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY]-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METOXY-, HYDROCHLORIDE, (8S-CIS)-
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-|_-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-
Daunorubicin Hydrochloride Imp. D (EP); Daunorubicin Imp. D (EP); Epirubicin Hydrochloride Imp. C (EP); Epirubicin Imp. C (EP); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-; Adriamycin, hydrochloride; ADM hydrochloride; ADR; Adriablastina CS; Adriacin; Adriamycin; Adriblastin; Adriblastina; Adriblastina RD; DOX HCl; Doxorubicin Hydrochloride; FI 106; FI 6804; Hydroxydaunorubicin hydrochloride; Lipo-Dox; Daunorubicin Hydrochloride Impurity D as Hydrochloride; Epirubicin Hydrochloride Impurity C as Hydrochloride; Daunorubicin Impurity D as Hydrochloride; Epirubicin Impurity C as Hydrochl
DOX
L-Lyxo-hexopyranoside, 3b-glycol-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-, hydrochloride